Prescription drug · ANDA
Pramipexole Dihydrochloride NDC 46708-005
Pramipexole dihydrochloride .5 mg/1 · Tablet · Oral · Alembic Pharmaceuticals Limited
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 46708-005-90 | 4670800059046708000590 | 90 TABLET in 1 BOTTLE (46708-005-90)Marketed from Mar 22, 2016 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Pramipexole Dihydrochloride
- Generic name (nonproprietary)
- pramipexole dihydrochloride
- Active ingredients
- Pramipexole dihydrochloride — .5 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- Alembic Pharmaceuticals LimitedNDC labeler code 46708
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 078894
- Marketing start
- Listing expires
- Other FDA classes
- Dopamine Agonists (Mechanism)
- Identifiers
- Product ID 46708-005_92f6ef1e-3256-45a7-a409-80dd85e95187SPL ID 92f6ef1e-3256-45a7-a409-80dd85e95187SPL set ID 92f6ef1e-3256-45a7-a409-80dd85e95187RxCUI 859033, 859040, 859044, 859048, 859052UNII 3D867NP06JUPC 0346708005900, 0346708007904, 0346708006907, 0346708003906, 0346708004903
- Pharmacologic class
- Nonergot Dopamine Agonist
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N446708000590followed by a unit qualifier and the quantityPackage 46708-0005-90. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Pramipexole dihydrochloride tablets are non-ergot dopamine agonist indicated for the treatment of: · Parkinson’s disease (PD) (1.1) 1.1 Parkinson's Disease Pramipexole dihydrochloride tablets are indicated for the treatment of Parkinson’s disease.
Excerpt only. Read the full label for complete information.
About NDC 46708-005
- What is NDC 46708-005?
- 46708-005 is the product NDC for Pramipexole Dihydrochloride, Pramipexole dihydrochloride .5 mg/1 tablet, listed with the FDA by Alembic Pharmaceuticals Limited. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Pramipexole Dihydrochloride.
- What is the active ingredient?
- Pramipexole dihydrochloride.
- Who is the labeler?
- Alembic Pharmaceuticals Limited, NDC labeler code 46708. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Pramipexole Dihydrochloride?
- 127 other product NDCs are listed under this name. See all Pramipexole Dihydrochloride NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Pramipexole Dihydrochloride products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Pramipexole dihydrochloride | Pramipexole dihydrochloride 2.25 mg/1 | Tablet, Extended releaseOral | Ingenus Pharmaceuticals, LLC | 50742-334 | 50742-0334-30 |
| Pramipexole dihydrochloride | Pramipexole dihydrochloride .375 mg/1 | Tablet, Extended releaseOral | Ingenus Pharmaceuticals, LLC | 50742-331 | 50742-0331-30 |
| Pramipexole dihydrochloride | Pramipexole dihydrochloride .75 mg/1 | Tablet, Extended releaseOral | Ingenus Pharmaceuticals, LLC | 50742-332 | 50742-0332-30 |
| Pramipexole dihydrochloride | Pramipexole dihydrochloride 1.5 mg/1 | Tablet, Extended releaseOral | Ingenus Pharmaceuticals, LLC | 50742-333 | 50742-0333-30 |
| Pramipexole dihydrochloride | Pramipexole dihydrochloride 4.5 mg/1 | Tablet, Extended releaseOral | Ingenus Pharmaceuticals, LLC | 50742-337 | 50742-0337-30 |
| Pramipexole dihydrochloride | Pramipexole dihydrochloride 3 mg/1 | Tablet, Extended releaseOral | Ingenus Pharmaceuticals, LLC | 50742-335 | 50742-0335-30 |
| Pramipexole dihydrochloride | Pramipexole dihydrochloride 3.75 mg/1 | Tablet, Extended releaseOral | Ingenus Pharmaceuticals, LLC | 50742-336 | 50742-0336-30 |
| Pramipexole Dihydrochloride | Pramipexole dihydrochloride .75 mg/1 | Tablet, Extended releaseOral | Vitruvias Therapeutics, Inc. | 69680-146 | 69680-0146-30 |
| pramipexole dihydrochloride | Pramipexole dihydrochloride .25 mg/1 | TabletOral | Strides Pharma Science Limited | 64380-747 | 64380-0747-0164380-0747-05 |
| pramipexole dihydrochloride | Pramipexole dihydrochloride .125 mg/1 | TabletOral | Strides Pharma Science Limited | 64380-746 | 64380-0746-05 |
Other NDCs under ANDA 078894
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Pramipexole Dihydrochloride | Pramipexole dihydrochloride .125 mg/1 | TabletOral | Alembic Pharmaceuticals Limited | 46708-003 |
| Pramipexole Dihydrochloride | Pramipexole dihydrochloride .25 mg/1 | TabletOral | Alembic Pharmaceuticals Limited | 46708-004 |
| Pramipexole Dihydrochloride | Pramipexole dihydrochloride 1 mg/1 | TabletOral | Alembic Pharmaceuticals Limited | 46708-006 |
| Pramipexole Dihydrochloride | Pramipexole dihydrochloride 1.5 mg/1 | TabletOral | Alembic Pharmaceuticals Limited | 46708-007 |
| Pramipexole Dihydrochloride | Pramipexole dihydrochloride .125 mg/1 | TabletOral | Alembic Pharmaceuticals Limited | 46708-611 |
| Pramipexole Dihydrochloride | Pramipexole dihydrochloride .25 mg/1 | TabletOral | Alembic Pharmaceuticals Limited | 46708-612 |
| Pramipexole Dihydrochloride | Pramipexole dihydrochloride .5 mg/1 | TabletOral | Alembic Pharmaceuticals Limited | 46708-613 |
| Pramipexole Dihydrochloride | Pramipexole dihydrochloride 1 mg/1 | TabletOral | Alembic Pharmaceuticals Limited | 46708-614 |
| Pramipexole Dihydrochloride | Pramipexole dihydrochloride 1.5 mg/1 | TabletOral | Alembic Pharmaceuticals Limited | 46708-615 |
| Pramipexole Dihydrochloride | Pramipexole dihydrochloride .125 mg/1 | TabletOral | Alembic Pharmaceuticals Inc. | 62332-003 |
| Pramipexole Dihydrochloride | Pramipexole dihydrochloride .25 mg/1 | TabletOral | Alembic Pharmaceuticals Inc. | 62332-004 |
| Pramipexole Dihydrochloride | Pramipexole dihydrochloride .5 mg/1 | TabletOral | Alembic Pharmaceuticals Inc. | 62332-005 |
| Pramipexole Dihydrochloride | Pramipexole dihydrochloride 1 mg/1 | TabletOral | Alembic Pharmaceuticals Inc. | 62332-006 |
| Pramipexole Dihydrochloride | Pramipexole dihydrochloride 1.5 mg/1 | TabletOral | Alembic Pharmaceuticals Inc. | 62332-007 |